Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
Huvudupphovsmän: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2013
|
Liknande verk
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
av: Cornelissen, B, et al.
Publicerad: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
av: Cornelissen, B, et al.
Publicerad: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
av: Malcolm, J, et al.
Publicerad: (2019) -
Radiopharmaceuticals for imaging and therapy.
av: Faulkner, S, et al.
Publicerad: (2011) -
Regulation of Radiopharmaceutical Products
av: V. V. Kosenko, et al.
Publicerad: (2022-12-01)